To hear about similar clinical trials, please enter your email below
Trial Title:
Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study
NCT ID:
NCT06472024
Condition:
Cancer
Nasopharyngeal Carcinoma
Mucositis
Conditions: Official terms:
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
Mucositis
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Procedure
Intervention name:
Verum Acupuncture
Description:
Acupuncture therapy uses filiform needles at a perpendicular angle at acupuncture points
to produce a therapeutic effect.
Arm group label:
Verum Acupuncture
Intervention type:
Procedure
Intervention name:
Sham Acupuncture
Description:
Sham Acupuncture therapy uses filiform needles but is only attached with tape to
acupuncture points
Arm group label:
Sham Acupuncture
Summary:
The goal of this clinical trial is to learn if acupuncture can play a role in reducing
pain and improving the quality of life of post-radiotherapy nasopharyngeal cancer
mucositis patients. The main questions it aims to answer are:
- Do manual acupuncture and medication therapy affect pain intensity as measured by
the visual analogue scale (VAS) in patients with oral mucositis compared with sham
manual acupuncture and medication?
Participants will receive acupuncture therapy 2 times a week for 3 weeks
Detailed description:
This is a clinical trial study to evaluate the role of acupuncture in pain relief and
improving the quality of life of nasopharyngeal cancer patients with post-radiotherapy
mucositis. Participants were 30 men/females with mucositis in post-radiotherapy
nasopharyngeal cancer aged 19-59 years. They will be divided into 2 groups: (1) verum
acupuncture and (2) sham acupuncture. Acupuncture is scheduled 2 times per week for 3
weeks. Research assessment on pain scale and improvement in quality of life
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Subjects who have been proven by anatomical pathology examination to have a
diagnosis of Nasopharyngeal Cancer.
- Subjects with adult Nasopharyngeal Cancer aged 19 years - 59 years.
- Nasopharyngeal Cancer Patients, who underwent bilateral Head and Neck radiotherapy.
- Patients diagnosed with mucositis.
- Willing to participate in the research until completion by signing an informed
consent.
Exclusion Criteria:
- Nasopharyngeal Cancer patients who have distant metastases (based on the Tumor Node
Metastasis (TNM) classification with the presence of metastases (M1)).
- Subjects who still smoke and consume alcohol to date.
- Patients have contraindications for manual acupuncture, namely the use of
anti-coagulant drugs, the presence of infection or wounds at the puncture site,
emergency conditions, and pregnancy.
- There is a history of allergy to stainless steel materials.
- Patients with blood clotting disorders; Platelets <50,000/μL, Absolute Neutrophil
Count (ANC) <1000/mm3, patients undergoing anticoagulant therapy with International
Normalized Ratio (INR) >2.47
Gender:
All
Minimum age:
19 Years
Maximum age:
59 Years
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
July 2024
Completion date:
September 2024
Lead sponsor:
Agency:
Indonesia University
Agency class:
Other
Source:
Indonesia University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06472024